Piekarska, A., Koślińska-Berkan, E., Wójcik, K., Skubała, A., Jabłkowski, M., Deroń, Z., & Berkan-Kawińska, A. (2016). Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population. Clin Exp Hepatol.

Piekarska, Anna, Ewa Koślińska-Berkan, Kamila Wójcik, Anna Skubała, Maciej Jabłkowski, Zbigniew Deroń, and Aleksandra Berkan-Kawińska. "Efficacy and Direct Costs of Chronic Hepatitis C Treatment With First Generation NS3/4A Protease Inhibitors in a Real Life Population." Clin Exp Hepatol 2016.

Piekarska, Anna, et al. "Efficacy and Direct Costs of Chronic Hepatitis C Treatment With First Generation NS3/4A Protease Inhibitors in a Real Life Population." Clin Exp Hepatol 2016.